Canopy Growth Corporation (CGC) vs Orchestra BioMed Holdings, Inc. (OBIO)
A side-by-side comparison of Canopy Growth Corporation and Orchestra BioMed Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CGC
Canopy Growth Corporation
$0.89HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
OBIO
Orchestra BioMed Holdings, Inc.
$5.86HealthcareDelayed quote: Oct 6, 2026, 12:09 PM EDT
Total return — CGC vs OBIO
growth of $100 · dividends reinvested · last 6yCGC -99.5% (-58.9%/yr)OBIO -47.1% (-10.1%/yr)OBIO compounded faster over this window
Log scale — wide-divergence pair
CGC OBIO
CGC vs OBIO: by the numbers
- •CGC is the larger company ($375M vs $351M market cap).
- •Both run net losses; CGC's is the smaller (-81.04% vs -184.60% net margin).
- •OBIO grew revenue faster over the past five years (148.45% vs -12.47% CAGR).
Metrics side by side
Valuation
| Metric | CGC | OBIO |
|---|---|---|
| P/S ratio | 1.62 | 10.97 |
| P/B ratio | 0.77 | 18.16 |
Profitability
| Metric | CGC | OBIO |
|---|---|---|
| Gross margin | 25.47% | 99.32% |
| Operating margin | -31.98% | -154.73% |
| Net margin | -81.04% | -184.60% |
| ROE | -38.57% | -200.64% |
| ROIC | -10.85% | -56.73% |
Growth (annualized)
| Metric | CGC | OBIO |
|---|---|---|
| Revenue CAGR (5Y) | -12.47% | 148.45% |
| Total return CAGR (5Y) | -63.36% | -9.35% |
Frequently asked
- Which has grown faster, CGC or OBIO?
- Over the past five years, OBIO grew revenue faster — CGC at a -12.47% CAGR versus OBIO at 148.45%.
- How have CGC and OBIO total returns compared?
- Over the past 5 years, CGC delivered -63.36% and OBIO delivered -9.35% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Canopy Growth ROEOrchestra BioMed ROECanopy Growth operating marginOrchestra BioMed operating marginCanopy Growth revenue growthOrchestra BioMed revenue growthCanopy Growth free cash flowOrchestra BioMed free cash flow
Canopy Growth & Orchestra BioMed appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.